Physician profile
David C Teague
NPI 1083682595
$4,008.35
in general payments reported to CMS, 2019-2025
9 companies · $73.62 in 2025
The $73.62 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $114 · 2021: $74.14 · 2022: $3,194 · 2023: $305 · 2024: $248 · 2025: $73.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $3,193.82 | 2022 | |
| Smith+Nephew, INC. | $281.76 | 2023-2024 | Trigen Intertan, Evos, Maverick |
| Stryker Corporation | $163.61 | 2021-2025 | Na |
| Acera Surgical, INC. | $154.46 | 2023 | Restrata Wound Matrix |
| Pylant Medical | $114.00 | 2020 | |
| Depuy Synthes Sales INC. | $42.65 | 2024 | Na, Tfn-Advance, Fibergraft Aeridyan Matrix |
| Pacira Pharmaceuticals Incorporated | $22.86 | 2025 | Zilretta |
| Vertex Pharmaceuticals Incorporated | $19.50 | 2025 | |
| Solventum Corporation | $15.69 | 2025 | V.A.C. Dermatac, Prevena, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Teague listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.